Generalized anxiety disorder (GAD) is a type of excessive worrying that consumes the lives of people who experience it. Symptoms can include fatigue, headaches, shortness of breath, and having a hard ...

DaylightRx is a 90-day treatment. The Food and Drug Administration (FDA) has cleared DaylightRx, a prescription digital therapeutic for the treatment of generalized anxiety disorder (GAD). DaylightRx ...

Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...

Cognitive behavioral therapy (CBT) should be considered first-line treatment for generalized anxiety disorder in adults, according to a systematic review and network meta-analysis of 66 randomized ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...

Occasionally worrying about an upcoming work presentation, a stressful family situation, or a complicated relationship is a natural part of life. But when that worry becomes excessive, frequent, and ...

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...

News Commentary - Treatments for Generalized Anxiety Disorder (GAD) are getting better and more accessible, which is good news ...

Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.

Too much worrying could be a reason ask a health professional about general anxiety disorder. It's a condition where a person feels very nervous most of the time, and it can happen to adults and ...

The U.S. Food and Drug Administration last week granted “breakthrough therapy” status to a form of the psychedelic drug LSD as a treatment for anxiety. The drug, a form of LSD (lysergide d-tartrate) ...

Helus Pharma (HELP) stock falls as the company posts mid-stage trial data for HLP004, a psychedelic-based therapy for generalized anxiety disorder. Read more here.